An Overview of Chemistry, Kinetics, Toxicity and Therapeutic Potential of Boldine in Neurological Disorders

被引:6
|
作者
Akotkar, Likhit [1 ]
Aswar, Urmila [1 ]
Ganeshpurkar, Ankit [2 ]
Raj, Ritik [3 ]
Pawar, Atmaram [4 ]
机构
[1] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmacol, Pune 411038, Maharashtra, India
[2] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Chem, Pune 411038, India
[3] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Biotechnol, Pune 411038, India
[4] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut, Pune 411038, India
关键词
Alkaloids; Antioxidant; Boldine; Aporphine; Neuroprotective; Toxicity; SPINAL-CORD-INJURY; MICROSOMAL LIPID-PEROXIDATION; OXIDATIVE STRESS; IN-VITRO; ALKALOID BOLDINE; PEUMUS-BOLDUS; ANTIOXIDANT ACTIVITY; APORPHINE ALKALOIDS; STATUS EPILEPTICUS; CELL-DEATH;
D O I
10.1007/s11064-023-03992-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Boldine is an alkaloid obtained from the medicinal herb Peumus boldus (Mol.) (Chilean boldo tree; boldo) and belongs to the family Monimiaceae. It exhibits a wide range of pharmacological effects such as antioxidant, anticancer, hepatoprotective, neuroprotective, and anti-diabetic properties. There is a dearth of information regarding its pharmacokinetics and toxicity in addition to its potential pharmacological activity. Boldine belongs to the aporphine alkaloid class and possesses lipophilic properties which enable its efficient absorption and distribution throughout the body, including the central nervous system. It exhibits potent free radical scavenging activity, thereby reducing oxidative stress and preventing neuronal damage. Through a variety of neuroprotective mechanisms, including suppression of AChE and BuChE activity, blocking of connexin-43 hemichannels, pannexin 1 channel, reduction of NF-& kappa;& beta; mediated interleukin release, and glutamate excitotoxicity which successfully reduces neuronal damage. These results point to its probable application in reducing neuroinflammation and oxidative stress in epilepsy, Alzheimer's disease (AD), and Parkinson's disease (PD). Moreover, its effects on serotonergic, dopaminergic, opioid, and cholinergic receptors were further investigated in order to determine its applicability for neurobehavioral dysfunctions. The article investigates the pharmacokinetics of boldine and reveals that it has a low oral bioavailability and a short half-life, requiring regular dosage to maintain therapeutic levels. The review studies boldine's potential therapeutic uses and mode of action while summarizing its neuroprotective benefits. Given the favorable results for boldine as a potential neurotherapeutic drug in laboratory animals, more research is required. However, in order to optimise its therapeutic potential, it must be more bioavailable with fewer detrimental side effects.
引用
收藏
页码:3283 / 3295
页数:13
相关论文
共 50 条
  • [41] Neurological Disorders and Glaucoma - An Overview
    Goebel, K.
    Erb, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2014, 231 (02) : 130 - 135
  • [42] FK506 and Its Analogs - Therapeutic Potential for Neurological Disorders
    Klettner, Alexa
    Herdegen, Thomas
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (03) : 153 - 162
  • [43] Nesfatin-1: A Biomarker and Potential Therapeutic Target in Neurological Disorders
    Siyu Zhou
    Jianfei Nao
    Neurochemical Research, 2024, 49 : 38 - 51
  • [44] The therapeutic potential of endogenous hippocampal stem cells for the treatment of neurological disorders
    Taylor, Chanel J.
    Jhaveri, Dhanisha J.
    Bartlett, Perry F.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2013, 7
  • [45] Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
    Singh, Kuldeep
    Bhushan, Bharat
    Chanchal, Dilip Kumar
    Sharma, Satish Kumar
    Rani, Ketki
    Yadav, Manoj Kumar
    Porwal, Prateek
    Kumar, Shivendra
    Sharma, Ashwani
    Virmani, Tarun
    Kumar, Girish
    Noman, Abdullah Al
    BEHAVIOURAL NEUROLOGY, 2023, 2023
  • [46] Therapeutic potential of Bergenin in the management of neurological-based diseases and disorders
    Rezaiezadeh, Hojjat
    Langarizadeh, Mohammad Amin
    Tavakoli, Marziye Ranjbar
    Sabokro, Mohammad
    Banazadeh, Mohammad
    Kohlmeier, Kristi A.
    Shabani, Mohammad
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (11) : 8349 - 8366
  • [47] GPR56: A potential therapeutic target for neurological and psychiatric disorders
    Qi, Wang
    Guan, Wei
    BIOCHEMICAL PHARMACOLOGY, 2024, 226
  • [48] Exploring the Therapeutic Potential of Peritoneal Dialysis (PD) in the Treatment of Neurological Disorders
    Cheng, Muyuan
    Ding, Yuchuan
    Kim, Enoch
    Geng, Xiaokun
    CELL TRANSPLANTATION, 2024, 33
  • [49] Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders
    White, Caitlin M.
    Ji, Sunggoan
    Cai, Huan
    Maudsley, Stuart
    Martin, Bronwen
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (05) : 661 - 666
  • [50] Beyond boundaries: The therapeutic potential of exosomes in neural microenvironments in neurological disorders
    Rasouli, Arefe
    Roshangar, Leila
    Hosseini, Mohammadbagher
    Pourmohammadfazel, Amir
    Nikzad, Sadeneh
    NEUROSCIENCE, 2024, 553 : 98 - 109